MyAverix Finance
F · Healthcare
CLINUVEL PHARMAC.ADRS1 (UR9A)
Biotechnology
CLINUVEL PHARMAC.ADRS1 (UR9A) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for UR9A
CLINUVEL PHARMAC.ADRS1 (UR9A) — FAQ
What is UR9A's P/E ratio?
The price-to-earnings (P/E) ratio for CLINUVEL PHARMAC.ADRS1 (UR9A) is 25.00 (data as of 2026-05-21).
Does CLINUVEL PHARMAC.ADRS1 pay a dividend?
Dividend yield is not available in the current snapshot for CLINUVEL PHARMAC.ADRS1 (UR9A). Check the MyAverix Finance app for the latest dividend data.
What sector is CLINUVEL PHARMAC.ADRS1 in?
CLINUVEL PHARMAC.ADRS1 (UR9A) is classified in the Healthcare sector (Biotechnology industry).
What exchange is UR9A listed on?
UR9A is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.